When was Elixinol Global founded?

Elixinol Global was founded in 2017 and raised its 1st funding round 1 year after it was founded.

Where is Elixinol Global located?

Elixinol Global is headquartered in Sydney, Australia.

How many employees does Elixinol Global have?

As of Apr 30, 2026, the latest employee count at Elixinol Global is 18.

Is Elixinol Global a funded company?

Elixinol Global is a funded company, having raised an undisclosed amount across 2 funding rounds to date. The company's 1st funding round was a $***** Post IPO round, raised on Sep 28, 2018.

When was the latest funding round of Elixinol Global?

Elixinol Global's latest funding was a $***** Post IPO round on Jun 13, 2019, with participation from 0 investor.

Where does Elixinol Global rank among its competitors?

Elixinol Global ranks 101st amongst 1371 active competitors, of which 36 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was cbdMD, which secured $2.25M in Dec, 2025.

Who are the top competitors of Elixinol Global?

Elixinol Global's top competitors include Puresport, Medterra and Naturecan. Among them, cbdMD secured the most recent funding round in December, 2025.

Elixinol Global - 2026 Company Profile, Team, Funding & Competitors

Company Details

Manufacturer of nutraceuticals cannabis-based products. It offers various hemp-derived CBD products for fitness, health, stress management, etc.

Website: www.elixinolglobal.com
Email ID: *****@elixinolglobal.com
Phone Number: +61 **********
Part Of

Key Metrics

Founded Year

2017

Location

Sydney, Australia

Stage

Public

Latest Funding Round

Post IPO, Jun 13, 2019, $*****

Investors

Regal Funds Management

Ranked

101^st among 1371 active competitors

Employee Count

18 as on Apr 30, 2026

Similar Companies

Puresport & 1846 more

Exit Details

Public

View Elixinol Global's full profile

Elixinol Global got listed on Aug 01, 2018.

Click here to take a look at Elixinol Global's IPO in detail

Elixinol Global has raised funding over 2 rounds. Its first funding round was on Sep 28, 2018. Elixinol Global has 1 institutional investor.

Here is the list of recent funding rounds of Elixinol Global:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 13, 2019	8276607	Post IPO	3648882	3996834	5170302	9275206
Sep 28, 2018	2188015	Post IPO	6225541	6593949	9170707	5915653

Access funding benchmarks and valuations. Sign up today!

View details of Elixinol Global's funding rounds and investors

The founders of Elixinol Global is Paul Benhaim.

Here are the details of Elixinol Global's key team members:

Paul Benhaim: Co-Founder of Elixinol Global.

View details of Elixinol Global's Founder profiles and Board Members

Elixinol Global's employee count trend

Elixinol Global has 18 employees as of Apr 26. Here is Elixinol Global's employee count trend over the years:

Employee count trend for Elixinol Global

Uncover Elixinol Global's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Elixinol Global include Puresport, Medterra and Naturecan. Here is the list of Top 10 competitors of Elixinol Global, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Puresport 2018, Bearsden (United Kingdom), Series A	Provider of cannabis-derived nutritional and wellness products	$6.48M	Five Seasons Ventures, Redrice Ventures & 1 others	50/100
2nd	Medterra 2017, Irvine (United States), Funding Raised	Provider of CBD therapeutic and nutraceuticals	-	Archytas Ventures	50/100
3rd	Naturecan 2019, Stockport (United Kingdom), Funding Raised	Manufacturer of hemp derived CBD products	-	Zag, VGC	47/100
4th	Demetrix 2017, Berkeley (United States), Series A	Provider of cannabinoid ingredients for pharmaceutical applications	$61M	Horizons Ventures, Tuatara Capital & 2 others	45/100
5th	Alphargreen Group Limited 2019, Covent Garden (United Kingdom), Seed	Provider of an online market place of cannabis products for various diseases	$4.85M	ENEXIS, Firestartr & 3 others	43/100
6th	cbdMD 2015, Charlotte (United States), Public	Provider of cannabis products	-	-	43/100
7th	Equilibria 2005, Chicago (United States), Seed	Offers CBD infused product for women's health	$1.97M	Salveo Capital, XY Ventures & 4 others	43/100
8th	Starseed 2013, Aylmer (Canada), Acquired	Provider of medical cannabis products to support health	-	United States Department of Agriculture	42/100
9th	Pico IV 2023, Sacramento (United States), Unfunded	Provider of CBD infused hydration therapies to improve health	-	-	41/100
10th	Nutritional High 2004, Toronto (Canada), Public	Provider of cannabis infused product development and distribution services	-	Canaccord Genuity Group, Gravitas Securities ... & 1 others	40/100
101st	Elixinol Global 2017, Sydney (Australia), Public	Manufacturer of nutraceuticals cannabis-based products	-	Regal Funds Management	27/100